shortagewatch

Home / Cancer and immune system / Buserelin

ATC L02AE01 · Endocrine Therapy

Buserelin shortage

As of 31 Oct 2026, Buserelin has a reported shortage in 1 of the 5 countries we track (Spain), covering 1 product.

Countries1/5
Products1packs or presentations
Short since3 Feb 202521 months ago
Earliest returnnot givencompany estimate
No return date1products
Main reasonNot stated
GermanyNo reported shortageItalyNo reported shortageSpain1 pack shortAustriaNo reported shortageBelgiumNo reported shortage

Timeline

Spain
20262027SUPREFACT DEPOT 9,45 mg IMPLANTE, 1 jeringa SUPREFACT DEPOT 9,45 mg IMPLANTE, 1 jeringa precargada + 3 implantes de 3,3 mgtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ESSUPREFACT DEPOT 9,45 mg IMPLANTE, 1 jeringa precargada + 3 implantes de 3,3 mgCheplapharm Arzneimittel Gmbh3 Feb 2025not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Leuprorelin Triptorelin